Intervention Protocol

Weight loss intervention through lifestyle modification or pharmacotherapy for obstructive sleep apnoea in adults

  1. Marzieh Hosseini Araghi1,*,
  2. Yen-Fu Chen2,
  3. Alison Jagielski3,
  4. Sopna Mannan Choudhury3,
  5. Dev Banerjee4,
  6. G Neil Thomas5,
  7. Shahrad Taheri3

Editorial Group: Cochrane Airways Group

Published Online: 12 DEC 2012

DOI: 10.1002/14651858.CD010281


How to Cite

Hosseini Araghi M, Chen YF, Jagielski A, Mannan Choudhury S, Banerjee D, Thomas GN, Taheri S. Weight loss intervention through lifestyle modification or pharmacotherapy for obstructive sleep apnoea in adults (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD010281. DOI: 10.1002/14651858.CD010281.

Author Information

  1. 1

    University of Birmingham, School of Health and Population Sciences, Birmingham, UK

  2. 2

    University of Birmingham, Public Health, Epidemiology and Biostatistics, Birmingham, UK

  3. 3

    University of Birmingham, Birmingham and Black Country NIHR CLAHRC, Birmingham, UK

  4. 4

    Heart of England NHS Foundation Trust, Academic Department of Sleep and Ventilation, Birmingham, UK

  5. 5

    University of Birmingham, Public Health, Birmingham, UK

*Marzieh Hosseini Araghi, School of Health and Population Sciences, University of Birmingham, Birmingham, UK. MXH079@bham.ac.uk. Marzieh.hosseiniaraghi@heartofengland.nhs.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 12 DEC 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of non-surgical weight loss interventions through lifestyle modification or pharmacotherapy as a treatment for obstructive sleep apnoea (OSA).

The review aims to test the hypothesis that OSA indices (and symptoms) would be favourably modified by non-surgical weight loss interventions in obese patients with OSA.